4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-24-050461
Pres&Chief Investment Officer sold 886,237 shares at an average $12.01 ($10,641,739)
- Pres&Chief Investment Officer acquired 886,237 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-23 | Option exercise | +10,796 | $3.85 | $41,565 | 18,847,343 | D |
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-23 | Sale | −10,796 | $12.00 | $129,552 | 18,836,547 | D |
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-24 | Option exercise | +185,946 | $3.85 | $715,892 | 19,022,493 | D |
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-24 | Sale | −185,946 | $12.00 | $2,231,352 | 18,836,547 | D |
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-26 | Option exercise | +689,495 | $3.85 | $2,654,556 | 19,526,042 | D |
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-26 | Sale | −689,495 | $12.01 | $8,280,835 | 18,836,547 | D |
| Derivatives | |||||||
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-23 | Option exercise · Stock Option (Right to Buy) | −10,796 | 16,099,804 | D | ||
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-24 | Option exercise · Stock Option (Right to Buy) | −185,946 | 15,913,858 | D | ||
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-12-26 | Option exercise · Stock Option (Right to Buy) | −689,495 | 15,224,363 | D | ||
| Open-market sales · 886,237 sh · avg $12.01 · $10,641,739 | |||||||
Loading xslF345X05/form4.xml…